A Study of a New Vaccine Against Two Types of Ebola
NCT05079750
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Ebola
Interventions
BIOLOGICAL:
ChAdOx1 biEBOV
Sponsor
University of Oxford